Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Heartflow (HTFL) EBITDA (2024 - 2025)

Heartflow has reported EBITDA over the past 2 years, most recently at -$24.3 million for Q4 2025.

  • For Q4 2025, EBITDA rose 25.76% year-over-year to -$24.3 million; the TTM value through Dec 2025 reached -$116.6 million, changed N/A, while the annual FY2025 figure was -$116.4 million, 20.42% down from the prior year.
  • EBITDA for Q4 2025 was -$24.3 million at Heartflow, up from -$50.6 million in the prior quarter.
  • Over five years, EBITDA peaked at -$8.9 million in Q2 2025 and troughed at -$50.6 million in Q3 2025.